Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin D3 in HIV Patients
NCT05306704Phase 3Completed
- Sponsor
- University of the Punjab
- Start
- Feb 2019
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitamin d in vitamin D deficiency (2 arms), sponsored by University of the Punjab. Primary endpoint: Change in Vitamin-D Levels at 12 weeks. Started Feb 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
vitamin D deficiency
Beyond the preview
Go deeper on NCT05306704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05306704.